Eduardo Vilar

37PUBLICATIONS
270CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Aug 21, 2026
The Immunological Landscape of Colorectal Pre-Cancers: A Systematic Review.

|Apr 03, 2026
Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures.

Nan Deng, Fahriye Duzagac, Ana M Bolivar

|Jan 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial.

Anna Morena D'Alise, Jason Willis, Fahriye Duzagac

|Nov 03, 2025
Germline Mutations as Cancer Drug Targets.

Tin-Yun Tang, Karen Colbert Maresso, Joanne Ngeow

|Oct 30, 2025
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Irene Maria Briata, Stefano Spinaci, Parijatham S Thomas

|Jun 27, 2025
Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells.

Ricardo A León-Letelier, Alejandro M Sevillano-Mantas, Yihui Chen

Pageof 7

Frequent Collaborators

4 joint publications

Laura Reyes-Uribe

4 joint publications

Scott Kopetz

4 joint publications

Melissa W Taggart

3 joint publications

Nan Deng